SC 13G
BIOCRYST PHARMACEUTICALS INC
- Company
- BIOCRYST PHARMACEUTICALS INC
- Filed
- April 17, 2020
- Accession Number
- 0000902664-20-001843
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →